Better Therapeutics (BTTX) Competitors $0.0002 0.00 (0.00%) As of 04/30/2025 03:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock BTTX vs. UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, and NTRAShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), and Natera (NTRA). These companies are all part of the "healthcare" industry. Better Therapeutics vs. UpHealth Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, community ranking, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings. Is UPHL or BTTX more profitable? Company Net Margins Return on Equity Return on Assets UpHealthN/A N/A N/A Better Therapeutics N/A N/A N/A Which has more volatility & risk, UPHL or BTTX? UpHealth has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Does the media favor UPHL or BTTX? In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score. Company Overall Sentiment UpHealth Neutral Better Therapeutics Neutral Which has stronger valuation and earnings, UPHL or BTTX? Better Therapeutics has lower revenue, but higher earnings than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00Better TherapeuticsN/AN/A-$39.76MN/AN/A Does the MarketBeat Community favor UPHL or BTTX? Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users. CompanyUnderperformOutperformUpHealthN/AN/ABetter TherapeuticsOutperform Votes541.67% Underperform Votes758.33% Do institutionals & insiders believe in UPHL or BTTX? 56.1% of UpHealth shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryBetter Therapeutics beats UpHealth on 4 of the 6 factors compared between the two stocks. Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$10,000.00$833.50M$5.49B$7.97BDividend YieldN/A2.55%5.11%4.23%P/E RatioN/A52.3422.6118.58Price / SalesN/A7.96397.51103.15Price / CashN/A26.1438.1834.62Price / BookN/A3.956.704.26Net Income-$39.76M-$5.50M$3.22B$248.31M7 Day PerformanceN/A-3.33%1.26%1.34%1 Month PerformanceN/A3.75%3.73%3.92%1 Year PerformanceN/A15.15%15.82%5.33% Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/A$0.00flatN/A-98.5%$10,000.00N/A0.0040UPHLUpHealthN/A$0.00flatN/A-100.0%$4,000.00$130M0.001,750ACONWAclarionN/A$0.03-0.6%N/A-48.0%$0.00$45,724.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$6.30-2.3%N/A+64.9%$0.00$1.34B0.001,520Positive NewsDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$23.93+3.7%N/A+8.8%$0.00$212.45M0.00230Upcoming EarningsShort Interest ↑Gap UpOTRKPOntrakN/A$0.23+0.0%N/A-45.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-4.7%N/A-80.3%$0.00$1.50B0.00500Gap UpHigh Trading VolumeTALKWTalkspaceN/A$0.12+6.5%N/A-57.1%$0.00$187.59M0.00500Positive NewsGap UpTOIIWOncology InstituteN/A$0.08-15.4%N/A-69.0%$0.00$393.41M0.00660Short Interest ↓News CoverageNTRANatera2.8621 of 5 stars$154.89+1.2%$175.76+13.5%+62.5%$20.94B$1.70B-88.013,020Upcoming EarningsInsider TradePositive News Related Companies and Tools Related Companies UPHL Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTTX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BTTX Stock Free BTTX Stock Alerts